Baidu sets May 18 board meeting on Q1 results
Baidu, Inc. will hold a board meeting on May 18, 2026 to approve its unaudited financial results and announcement for the three months ended March 31, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Baidu, Inc. will hold a board meeting on May 18, 2026 to approve its unaudited financial results and announcement for the three months ended March 31, 2026.
The company plans to post the first quarter 2026 results announcement on its investor relations website and the Hong Kong Stock Exchange website after Hong Kong trading hours and before the opening of the U.S. market on the same day.
Management will host an earnings conference call at 8:00 PM Beijing/Hong Kong Time (8:00 AM U.S. Eastern Time) on May 18, 2026, with live and archived webcasts available via Baidu’s investor relations site.
Key Figures
Key Terms
weighted voting rights structure financial
earnings conference call financial
unaudited results financial
archived webcast financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Baidu (BIDU) report its first quarter 2026 financial results?
What period will Baidu’s upcoming Q1 2026 financial results cover?
When is Baidu’s Q1 2026 earnings conference call scheduled and in which time zones?
How can investors and analysts join Baidu’s Q1 2026 earnings call?
Will a replay of Baidu’s Q1 2026 earnings conference call be available?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2026
Commission File Number: 000-51469
BAIDU, INC.
Baidu Campus
No. 10 Shangdi 10th Street
Haidian District, Beijing 100085
The People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 | Announcement – Date of Board Meeting | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BAIDU, INC. | ||||
| By |
: | /s/ Haijian He | ||
| Name |
: | Haijian He | ||
| Title |
: | Chief Financial Officer | ||
Date: April 23, 2026
Exhibit 99.1
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Under our weighted voting rights structure, our share capital comprises Class A ordinary shares and Class B ordinary shares. Each Class A ordinary share entitles the holder to exercise one vote, and each Class B ordinary share entitles the holder to exercise 10 votes, respectively, on all matters subject to the vote at general meetings of the Company. Shareholders and prospective investors should be aware of the potential risks of investing in a company with a weighted voting rights structure. Our American depositary shares, each representing eight of our Class A ordinary shares, are listed on Nasdaq in the United States under the symbol BIDU.
Baidu, Inc.
百度集團股份有限公司
(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock Codes: 9888 (HKD counter) and 89888 (RMB counter))
DATE OF BOARD MEETING
Our board of directors will hold a board meeting on Monday, May 18, 2026 for the purposes of, among other matters, approving our unaudited results and announcement for the three months ended March 31, 2026 (the “First Quarter 2026 Financial Results Announcement”).
We will upload the First Quarter 2026 Financial Results Announcement to the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the website of the Company (https://ir.baidu.com) on Monday, May 18, 2026 (Beijing/Hong Kong Time), after the trading hours of the Stock Exchange and before the opening of the U.S. market.
The Company’s management will hold an earnings conference call at 8:00 PM on Monday, May 18, 2026, Beijing/Hong Kong Time (8:00 AM on May 18, 2026, U.S. Eastern Time).
Interested parties may register in advance of the conference call using the link provided below. Dial-in number, passcode, and unique access PIN will be provided by email upon registration.
Interested parties may visit the link below for pre-registration, which automatically directs visitors to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”.
PRE-REGISTRATION LINK: https://s1.c-conf.com/diamondpass/10054331-iu876y.html
In the 10 minutes prior to the call start time, participants may use the conference access information (including dial-in number(s), direct event passcode and unique registrant ID) provided in the confirmation email following pre-registration.
1
Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.
A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331
| By order of the Board |
| Baidu, Inc. |
| Mr. Robin Yanhong Li |
| Chairman of the Board and Chief Executive Officer |
Hong Kong, April 23, 2026
As at the date of this announcement, the board of directors of the Company comprises Mr. Robin Yanhong Li as director, and Mr. Yuanqing Yang, Mr. Jixun Foo, Ms. Sandy Ran Xu and Ms. Xiaodan Liu as independent directors.
2